DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ibrahim MA, Ashour OM, Ibrahim YF, El-Bitar HI, Gomaa W, Abdel-Rahim SR.
Angiotensin-converting enzyme inhibition and angiotensin AT (1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Pharmacol Res 2009;
60: 373-81
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.